{"schema_version":"secwatch.filing_event.v1","accession":"0001636422-26-000010","form_type":"8-K","ticker":"HCAT","cik":"0001636422","company_name":"Health Catalyst, Inc.","filed_at":"2026-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.706666+00:00","generated_at":"2026-05-16T08:26:01.141103+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Health Catalyst CCO Kevin Freeman to Depart, Remain as Senior Advisor","bullets":["Kevin Freeman will cease serving as Chief Commercial Officer on February 1, 2026.","Company expects to enter a separation agreement and independent contractor agreement for senior advisor role starting February 2, 2026.","Separation benefits under Executive Severance Plan as summarized in May 2025 proxy statement.","Transition intended to enable smooth handover of commercial responsibilities."],"urls":{"canonical":"https://secwatch.observer/filing/0001636422-26-000010","json":"https://secwatch.observer/filing/0001636422-26-000010.json","markdown":"https://secwatch.observer/filing/0001636422-26-000010.md","text":"https://secwatch.observer/filing/0001636422-26-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1636422/000163642226000010/0001636422-26-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1636422/000163642226000010/hcat-20260120.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T08:26:01.141103+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}